Dyne Therapeutics (DYN) Amortizatization of Intangibles (2020)

Dyne Therapeutics' (DYN) quarterly Amortizatization of Intangibles came in at $1000.0 in Q2 2020, down 91.67% on a QoQ basis from $12000.0 in Q1 2020.

Dyne Therapeutics (DYN) Amortizatization of Intangibles (2020) Analysis & Trends

Dyne Therapeutics (DYN) has 1 years of Amortizatization of Intangibles data on file, last reported at $1000.0 in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Dyne Therapeutics 4.24 Bn 4.24 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2020 1,000.00
Jun 30, 2020 1,000.00
Mar 31, 2020 12,000.00
Mar 31, 2020 12,000.00